The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40 View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-07

AUTHORS

Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer, Christine K. Zoon, Kelley M. Kidwell, André Robidoux, Luis Baez-Diaz, Adam M. Brufsky, Rita S. Mehta, Louis Fehrenbacher, James A. Young, Francis M. Senecal, Rakesh Gaur, Richard G. Margolese, Paul T. Adams, Howard M. Gross, Joseph P. Costantino, Soonmyung Paik, Sandra M. Swain, Eleftherios P. Mamounas, Norman Wolmark

ABSTRACT

BACKGROUND: NRG Oncology/NSABP trial B-40 tested the impact of adding bevacizumab (bev) to neoadjuvant chemotherapy for operable breast cancer. Secondary endpoints included rates of surgical complications after surgery in patients who did or did not receive bev. METHODS: A total of 1206 women with HER2-negative operable breast cancer were randomly assigned to receive one of three different docetaxel-plus-anthracycline-based regimens, without or with bev (15 mg/kg every 3 weeks) for the first 6 of 8 cycles and for 10 doses postoperatively. Surgical complications were assessed from date of surgery through 24 months following study entry. RESULTS: Early surgical complications were significantly more frequent in the bev group (25.4 vs. 18.9%; trend test p = 0.008), but most were grade 1-2. Early noninfectious wound dehiscences were infrequent and not significantly different (5.4 vs. 3.1%; trend test p = 0.15). Long-term noninfectious wound complications were significantly higher for patients receiving bev (11.8 vs. 5.1%; trend test p = 0.0007), but the incidence of grade ≥3 wound dehiscence was low in both groups (<1%). Among 193 patients undergoing expander or implant reconstructions, 19 (19.6%) of 97 in the bev-receiving group versus 10 (10.4%) of 96 in the non-bev group had grade ≥3 complications (Pearson, p = 0.11). CONCLUSIONS: Overall, adding bev increased surgical complications, but most serious complications were not significantly increased. In particular, the need for surgical intervention in patients undergoing breast reconstruction with prosthetic implants was higher with bev but was not statistically significantly different. With precautions, bev can be used safely perioperatively in patients undergoing surgery for breast cancer. More... »

PAGES

1853-1860

References to SciGraph publications

  • 2012-05. Impact of preoperative targeted therapy on postoperative complications after resection of colorectal liver metastases in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2015-09. Wound healing complications in brain tumor patients on Bevacizumab in JOURNAL OF NEURO-ONCOLOGY
  • 2014-06. Bevacizumab Doubles the Early Postoperative Complication Rate after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis of Colorectal Origin in ANNALS OF SURGICAL ONCOLOGY
  • 1993-04. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo in NATURE
  • 2011-03. Does Neoadjuvant Bevacizumab Increase Surgical Complications in Breast Surgery? in ANNALS OF SURGICAL ONCOLOGY
  • 2016-08. SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2010-01. Impact of Preoperative Bevacizumab on Complications After Resection of Colorectal Liver Metastases: Case-Matched Control Study in WORLD JOURNAL OF SURGERY
  • 2014-10. Bevacizumab: A Review of Its Use in Advanced Cancer in DRUGS
  • 2013-09. Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-09. Prophylactic plastic surgery closure of neurosurgical scalp incisions reduces the incidence of wound complications in previously-operated patients treated with bevacizumab (Avastin®) and radiation in JOURNAL OF NEURO-ONCOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1245/s10434-016-5662-9

    DOI

    http://dx.doi.org/10.1245/s10434-016-5662-9

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1031480530

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/27864694


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Anthracyclines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Combined Chemotherapy Protocols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bevacizumab", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Breast Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Combined Modality Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Docetaxel", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Follow-Up Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mammaplasty", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mastectomy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prognosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Surgical Wound Infection", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Survival Rate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Taxoids", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Virginia Commonwealth University", 
              "id": "https://www.grid.ac/institutes/grid.224260.0", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bear", 
            "givenName": "Harry D.", 
            "id": "sg:person.01127633164.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127633164.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Pittsburgh", 
              "id": "https://www.grid.ac/institutes/grid.21925.3d", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "University of Pittsburgh, Pittsburgh, PA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tang", 
            "givenName": "Gong", 
            "id": "sg:person.0743272655.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743272655.74"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Pittsburgh Cancer Institute", 
              "id": "https://www.grid.ac/institutes/grid.478063.e", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "University of Pittsburgh Cancer Institute School of Medicine, Pittsburgh, PA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rastogi", 
            "givenName": "Priya", 
            "id": "sg:person.01034766537.68", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034766537.68"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Virginia Commonwealth University", 
              "id": "https://www.grid.ac/institutes/grid.224260.0", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Geyer", 
            "givenName": "Charles E.", 
            "id": "sg:person.01171332245.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171332245.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Virginia Commonwealth University", 
              "id": "https://www.grid.ac/institutes/grid.224260.0", 
              "name": [
                "Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zoon", 
            "givenName": "Christine K.", 
            "id": "sg:person.0623725744.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623725744.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Michigan\u2013Ann Arbor", 
              "id": "https://www.grid.ac/institutes/grid.214458.e", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "University of Pittsburgh, Pittsburgh, PA, USA", 
                "Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kidwell", 
            "givenName": "Kelley M.", 
            "id": "sg:person.01020741650.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020741650.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al", 
              "id": "https://www.grid.ac/institutes/grid.410559.c", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montr\u00e9al, QC, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Robidoux", 
            "givenName": "Andr\u00e9", 
            "id": "sg:person.01314431247.04", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314431247.04"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Pittsburgh", 
              "id": "https://www.grid.ac/institutes/grid.21925.3d", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "San Juan MBCCOP, San Juan, PR, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Baez-Diaz", 
            "givenName": "Luis", 
            "id": "sg:person.01242063055.51", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242063055.51"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Pittsburgh", 
              "id": "https://www.grid.ac/institutes/grid.21925.3d", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Brufsky", 
            "givenName": "Adam M.", 
            "id": "sg:person.01307117455.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307117455.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of California, Irvine", 
              "id": "https://www.grid.ac/institutes/grid.266093.8", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "School of Medicine, Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mehta", 
            "givenName": "Rita S.", 
            "id": "sg:person.01034467337.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034467337.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Kaiser Permanente", 
              "id": "https://www.grid.ac/institutes/grid.280062.e", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fehrenbacher", 
            "givenName": "Louis", 
            "id": "sg:person.01277026103.87", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277026103.87"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Colorado Cancer Research Program", 
              "id": "https://www.grid.ac/institutes/grid.470273.5", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "CCOP, Colorado Cancer Research Program, Colorado Springs, CO, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Young", 
            "givenName": "James A.", 
            "id": "sg:person.0701020555.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701020555.11"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Northwest Medical Specialties", 
              "id": "https://www.grid.ac/institutes/grid.492880.f", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "CCOP, North-West Medical Specialties, Tacoma, WA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Senecal", 
            "givenName": "Francis M.", 
            "id": "sg:person.0747133755.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747133755.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "National Cancer Institute", 
              "id": "https://www.grid.ac/institutes/grid.48336.3a", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Kansas City Clinical Oncology Program, Kansas City, MO, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gaur", 
            "givenName": "Rakesh", 
            "id": "sg:person.0715716543.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715716543.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Pittsburgh", 
              "id": "https://www.grid.ac/institutes/grid.21925.3d", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Jewish General Hospital, McGill University, Montr\u00e9al, QC, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Margolese", 
            "givenName": "Richard G.", 
            "id": "sg:person.01127411327.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127411327.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Genesys Regional Medical Center", 
              "id": "https://www.grid.ac/institutes/grid.415497.a", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Genesys Regional Medical Center, Grand Blanc, MI, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Adams", 
            "givenName": "Paul T.", 
            "id": "sg:person.07743640715.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07743640715.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Pittsburgh", 
              "id": "https://www.grid.ac/institutes/grid.21925.3d", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Dayton CCOP, Dayton, OH, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gross", 
            "givenName": "Howard M.", 
            "id": "sg:person.01270466360.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270466360.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Pittsburgh", 
              "id": "https://www.grid.ac/institutes/grid.21925.3d", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "University of Pittsburgh, Pittsburgh, PA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Costantino", 
            "givenName": "Joseph P.", 
            "id": "sg:person.0675501121.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675501121.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Yonsei University", 
              "id": "https://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Paik", 
            "givenName": "Soonmyung", 
            "id": "sg:person.014545336422.51", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014545336422.51"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Georgetown University Medical Center", 
              "id": "https://www.grid.ac/institutes/grid.411667.3", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Washington Cancer Institute, Washington Hospital Center, Washington, DC, USA", 
                "Georgetown University Medical Center, Washington, DC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Swain", 
            "givenName": "Sandra M.", 
            "id": "sg:person.07442661237.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07442661237.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Orlando Health", 
              "id": "https://www.grid.ac/institutes/grid.416912.9", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "UF Health Cancer Center at Orlando Health, Orlando, FL, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mamounas", 
            "givenName": "Eleftherios P.", 
            "id": "sg:person.014177637317.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014177637317.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Allegheny Health Network", 
              "id": "https://www.grid.ac/institutes/grid.417046.0", 
              "name": [
                "NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA", 
                "Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wolmark", 
            "givenName": "Norman", 
            "id": "sg:person.0744516345.37", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744516345.37"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00268-009-0251-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002430554", 
              "https://doi.org/10.1007/s00268-009-0251-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00268-009-0251-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002430554", 
              "https://doi.org/10.1007/s00268-009-0251-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00268-009-0251-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002430554", 
              "https://doi.org/10.1007/s00268-009-0251-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-013-2682-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003608302", 
              "https://doi.org/10.1007/s10549-013-2682-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2217/fon.12.22", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006755830"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.jocn.2014.05.054", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008673264"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-014-1482-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013120563", 
              "https://doi.org/10.1007/s11060-014-1482-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/362841a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013132150", 
              "https://doi.org/10.1038/362841a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa1111097", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014405968"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/annonc/mdt361", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014803302"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.clbc.2011.04.002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015515225"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ejca.2011.11.021", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020551811"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-016-3889-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022566981", 
              "https://doi.org/10.1007/s10549-016-3889-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-016-3889-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022566981", 
              "https://doi.org/10.1007/s10549-016-3889-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00384-011-1360-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022743009", 
              "https://doi.org/10.1007/s00384-011-1360-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ejso.2011.06.004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024788330"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/sap.0b013e31824e5e57", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028219190"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/sap.0b013e31824e5e57", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028219190"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1470-2045(09)70341-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028408070"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1470-2045(13)70335-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030458704"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejm197111182852108", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031952402"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2010.28.0982", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032315475"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/cad.0b013e328349c7bb", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033215039"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/cad.0b013e328349c7bb", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033215039"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa072113", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033842397"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cncr.25573", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034217020"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s40265-014-0302-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034241465", 
              "https://doi.org/10.1007/s40265-014-0302-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s40265-014-0302-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034241465", 
              "https://doi.org/10.1007/s40265-014-0302-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1245/s10434-013-3442-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038883660", 
              "https://doi.org/10.1245/s10434-013-3442-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/annonc/mdu455", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038938305"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/sap.0b013e3181828141", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039490245"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/sap.0b013e3181828141", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039490245"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/sap.0b013e3181828141", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039490245"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2008.17.7857", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039795259"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ctrv.2014.05.006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041901798"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejm197108122850711", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042994614"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1245/s10434-010-1366-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043413784", 
              "https://doi.org/10.1245/s10434-010-1366-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2008.21.6457", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046932078"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3322/canjclin.22.4.226", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049016780"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-015-1868-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049649008", 
              "https://doi.org/10.1007/s11060-015-1868-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-015-1868-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049649008", 
              "https://doi.org/10.1007/s11060-015-1868-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1470-2045(15)00041-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050365925"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/0008-5472.sabcs13-s1-03", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1063223427"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1538-7445.sabcs15-s2-05", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1063275973"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1078308596", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1083175627", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/0471249688", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1098661133"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/0471249688", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1098661133"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2017-07", 
        "datePublishedReg": "2017-07-01", 
        "description": "BACKGROUND: NRG Oncology/NSABP trial B-40 tested the impact of adding bevacizumab (bev) to neoadjuvant chemotherapy for operable breast cancer. Secondary endpoints included rates of surgical complications after surgery in patients who did or did not receive bev.\nMETHODS: A total of 1206 women with HER2-negative operable breast cancer were randomly assigned to receive one of three different docetaxel-plus-anthracycline-based regimens, without or with bev (15\u00a0mg/kg every 3\u00a0weeks) for the first 6 of 8 cycles and for 10 doses postoperatively. Surgical complications were assessed from date of surgery through 24\u00a0months following study entry.\nRESULTS: Early surgical complications were significantly more frequent in the bev group (25.4 vs. 18.9%; trend test p = 0.008), but most were grade 1-2. Early noninfectious wound dehiscences were infrequent and not significantly different (5.4 vs. 3.1%; trend test p = 0.15). Long-term noninfectious wound complications were significantly higher for patients receiving bev (11.8 vs. 5.1%; trend test p = 0.0007), but the incidence of grade \u22653 wound dehiscence was low in both groups (<1%). Among 193 patients undergoing expander or implant reconstructions, 19 (19.6%) of 97 in the bev-receiving group versus 10 (10.4%) of 96 in the non-bev group had grade \u22653 complications (Pearson, p = 0.11).\nCONCLUSIONS: Overall, adding bev increased surgical complications, but most serious complications were not significantly increased. In particular, the need for surgical intervention in patients undergoing breast reconstruction with prosthetic implants was higher with bev but was not statistically significantly different. With precautions, bev can be used safely perioperatively in patients undergoing surgery for breast cancer.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1245/s10434-016-5662-9", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.3804391", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.3802775", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.3536478", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.3536471", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.3806135", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2693540", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1105545", 
            "issn": [
              "1068-9265", 
              "1534-4681"
            ], 
            "name": "Annals of Surgical Oncology", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "7", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "24"
          }
        ], 
        "name": "The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40", 
        "pagination": "1853-1860", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "95f74efa61ae61448038380ccd0857ee50f03478f7a3143771f201433f8a5704"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "27864694"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "9420840"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1245/s10434-016-5662-9"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1031480530"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1245/s10434-016-5662-9", 
          "https://app.dimensions.ai/details/publication/pub.1031480530"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T12:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70037_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1245%2Fs10434-016-5662-9"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-016-5662-9'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-016-5662-9'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-016-5662-9'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-016-5662-9'


     

    This table displays all metadata directly associated to this object as RDF triples.

    477 TRIPLES      21 PREDICATES      83 URIs      37 LITERALS      25 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1245/s10434-016-5662-9 schema:about N1e2ce7b117b647c385645c6c4186f4dc
    2 N2a116291184442b7ac01f781df84c7c4
    3 N464daa90000c4bdbae7e490e80f9e11d
    4 N4f74a8102537451988ab3b9295ef9573
    5 N56e518758df243f6a9fe81f005b34471
    6 N6e0b86a7759a4e098a93b6b092a417b4
    7 N82964493be9d40be9228a2d5432a8283
    8 N9f807c4839774d789d6b4dd2dabbc9e5
    9 Na8371715f4bc4a358ad89de6e5d00d62
    10 Nb62eab70716547f9ad9271951aab4946
    11 Nc32b4bc8a6e54c7f834261392146eb4c
    12 Nd2901722d4084de09ccc250405ab3010
    13 Nd62419b01cb8463d88ca8d34f66a4fd4
    14 Nfc77310fe1834c7eb01bf3e62a187c95
    15 Nfcea0fb11adc49eab1aff8f1f11d7138
    16 Nfed7ea263d804e6d855d1ed4389adfba
    17 anzsrc-for:11
    18 anzsrc-for:1103
    19 schema:author Nbebfdd79ee1748d1818d1d172e0f24d7
    20 schema:citation sg:pub.10.1007/s00268-009-0251-8
    21 sg:pub.10.1007/s00384-011-1360-z
    22 sg:pub.10.1007/s10549-013-2682-z
    23 sg:pub.10.1007/s10549-016-3889-6
    24 sg:pub.10.1007/s11060-014-1482-6
    25 sg:pub.10.1007/s11060-015-1868-0
    26 sg:pub.10.1007/s40265-014-0302-9
    27 sg:pub.10.1038/362841a0
    28 sg:pub.10.1245/s10434-010-1366-8
    29 sg:pub.10.1245/s10434-013-3442-3
    30 https://app.dimensions.ai/details/publication/pub.1078308596
    31 https://app.dimensions.ai/details/publication/pub.1083175627
    32 https://doi.org/10.1002/0471249688
    33 https://doi.org/10.1002/cncr.25573
    34 https://doi.org/10.1016/j.clbc.2011.04.002
    35 https://doi.org/10.1016/j.ctrv.2014.05.006
    36 https://doi.org/10.1016/j.ejca.2011.11.021
    37 https://doi.org/10.1016/j.ejso.2011.06.004
    38 https://doi.org/10.1016/j.jocn.2014.05.054
    39 https://doi.org/10.1016/s1470-2045(09)70341-9
    40 https://doi.org/10.1016/s1470-2045(13)70335-8
    41 https://doi.org/10.1016/s1470-2045(15)00041-8
    42 https://doi.org/10.1056/nejm197108122850711
    43 https://doi.org/10.1056/nejm197111182852108
    44 https://doi.org/10.1056/nejmoa072113
    45 https://doi.org/10.1056/nejmoa1111097
    46 https://doi.org/10.1093/annonc/mdt361
    47 https://doi.org/10.1093/annonc/mdu455
    48 https://doi.org/10.1097/cad.0b013e328349c7bb
    49 https://doi.org/10.1097/sap.0b013e3181828141
    50 https://doi.org/10.1097/sap.0b013e31824e5e57
    51 https://doi.org/10.1158/0008-5472.sabcs13-s1-03
    52 https://doi.org/10.1158/1538-7445.sabcs15-s2-05
    53 https://doi.org/10.1200/jco.2008.17.7857
    54 https://doi.org/10.1200/jco.2008.21.6457
    55 https://doi.org/10.1200/jco.2010.28.0982
    56 https://doi.org/10.2217/fon.12.22
    57 https://doi.org/10.3322/canjclin.22.4.226
    58 schema:datePublished 2017-07
    59 schema:datePublishedReg 2017-07-01
    60 schema:description BACKGROUND: NRG Oncology/NSABP trial B-40 tested the impact of adding bevacizumab (bev) to neoadjuvant chemotherapy for operable breast cancer. Secondary endpoints included rates of surgical complications after surgery in patients who did or did not receive bev. METHODS: A total of 1206 women with HER2-negative operable breast cancer were randomly assigned to receive one of three different docetaxel-plus-anthracycline-based regimens, without or with bev (15 mg/kg every 3 weeks) for the first 6 of 8 cycles and for 10 doses postoperatively. Surgical complications were assessed from date of surgery through 24 months following study entry. RESULTS: Early surgical complications were significantly more frequent in the bev group (25.4 vs. 18.9%; trend test p = 0.008), but most were grade 1-2. Early noninfectious wound dehiscences were infrequent and not significantly different (5.4 vs. 3.1%; trend test p = 0.15). Long-term noninfectious wound complications were significantly higher for patients receiving bev (11.8 vs. 5.1%; trend test p = 0.0007), but the incidence of grade ≥3 wound dehiscence was low in both groups (<1%). Among 193 patients undergoing expander or implant reconstructions, 19 (19.6%) of 97 in the bev-receiving group versus 10 (10.4%) of 96 in the non-bev group had grade ≥3 complications (Pearson, p = 0.11). CONCLUSIONS: Overall, adding bev increased surgical complications, but most serious complications were not significantly increased. In particular, the need for surgical intervention in patients undergoing breast reconstruction with prosthetic implants was higher with bev but was not statistically significantly different. With precautions, bev can be used safely perioperatively in patients undergoing surgery for breast cancer.
    61 schema:genre research_article
    62 schema:inLanguage en
    63 schema:isAccessibleForFree false
    64 schema:isPartOf N2875d1b1fc124bdeb011701db688379b
    65 N663786c056c741fe87e68bd9e145bce9
    66 sg:journal.1105545
    67 schema:name The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40
    68 schema:pagination 1853-1860
    69 schema:productId N669b1deefe624da7bac87b88710f380e
    70 N8ca98bf976834efaad5436efd3a19f64
    71 Na0a1c16dbdbb4520aca5b638f97dd71a
    72 Nb00940d777d4498aa35a160b153b7917
    73 Nb30898ffc6a941078cfc55b37a236036
    74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031480530
    75 https://doi.org/10.1245/s10434-016-5662-9
    76 schema:sdDatePublished 2019-04-11T12:37
    77 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    78 schema:sdPublisher Nd91bc18879c4456f84805f8e11f493ea
    79 schema:url https://link.springer.com/10.1245%2Fs10434-016-5662-9
    80 sgo:license sg:explorer/license/
    81 sgo:sdDataset articles
    82 rdf:type schema:ScholarlyArticle
    83 N08cb851a582442e0a26e1cf851681246 rdf:first sg:person.0747133755.49
    84 rdf:rest N651f1c71fc974ae5baab80ec35ff59ac
    85 N0b142972787341eb873ef427dfbae339 rdf:first sg:person.0675501121.41
    86 rdf:rest N52dedbbb23ff44ee8a7bc9a8d3aa0d0e
    87 N1e2ce7b117b647c385645c6c4186f4dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    88 schema:name Prognosis
    89 rdf:type schema:DefinedTerm
    90 N1f2cf4744c654ae4b8e19fb408d886ac rdf:first sg:person.01277026103.87
    91 rdf:rest N47e50d93684e4fd4a650d146bf172e15
    92 N1fd84f0b8dfa494c8a045392294a674b rdf:first sg:person.0743272655.74
    93 rdf:rest Nca12cb392c9e4254b677eb54746dd692
    94 N2875d1b1fc124bdeb011701db688379b schema:volumeNumber 24
    95 rdf:type schema:PublicationVolume
    96 N2a116291184442b7ac01f781df84c7c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    97 schema:name Antineoplastic Combined Chemotherapy Protocols
    98 rdf:type schema:DefinedTerm
    99 N2dbbce4d79094f04b13e8c950accf555 rdf:first sg:person.01020741650.38
    100 rdf:rest N392aedb5bd604f0db1d576ea9cbc4910
    101 N315ee4eb0a7045fabc70a2cc8d2a6aef rdf:first sg:person.01242063055.51
    102 rdf:rest N58ab791d5455479eb0a167e520f490c5
    103 N392aedb5bd604f0db1d576ea9cbc4910 rdf:first sg:person.01314431247.04
    104 rdf:rest N315ee4eb0a7045fabc70a2cc8d2a6aef
    105 N40b1b5c104c949a58afcdabf69d5da79 rdf:first sg:person.014177637317.92
    106 rdf:rest Ne214c0fd730e473282a354002f60f04c
    107 N45c584749bca400899639881a5af0e49 rdf:first sg:person.07743640715.33
    108 rdf:rest Nadfeef6db7494201b62ed1e976bc4554
    109 N464daa90000c4bdbae7e490e80f9e11d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Combined Modality Therapy
    111 rdf:type schema:DefinedTerm
    112 N47e50d93684e4fd4a650d146bf172e15 rdf:first sg:person.0701020555.11
    113 rdf:rest N08cb851a582442e0a26e1cf851681246
    114 N4f74a8102537451988ab3b9295ef9573 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Humans
    116 rdf:type schema:DefinedTerm
    117 N52dedbbb23ff44ee8a7bc9a8d3aa0d0e rdf:first sg:person.014545336422.51
    118 rdf:rest Nf4e6f62fb22e43f48cc556d39fa0bce0
    119 N56e518758df243f6a9fe81f005b34471 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Female
    121 rdf:type schema:DefinedTerm
    122 N58ab791d5455479eb0a167e520f490c5 rdf:first sg:person.01307117455.25
    123 rdf:rest N927b228a427149b6b7d3e6d0024569c7
    124 N651f1c71fc974ae5baab80ec35ff59ac rdf:first sg:person.0715716543.14
    125 rdf:rest N90469c86a6ae4907bcd66cda0d0384a6
    126 N663786c056c741fe87e68bd9e145bce9 schema:issueNumber 7
    127 rdf:type schema:PublicationIssue
    128 N669b1deefe624da7bac87b88710f380e schema:name nlm_unique_id
    129 schema:value 9420840
    130 rdf:type schema:PropertyValue
    131 N6e0b86a7759a4e098a93b6b092a417b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Taxoids
    133 rdf:type schema:DefinedTerm
    134 N82964493be9d40be9228a2d5432a8283 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Anthracyclines
    136 rdf:type schema:DefinedTerm
    137 N8ca98bf976834efaad5436efd3a19f64 schema:name dimensions_id
    138 schema:value pub.1031480530
    139 rdf:type schema:PropertyValue
    140 N90469c86a6ae4907bcd66cda0d0384a6 rdf:first sg:person.01127411327.42
    141 rdf:rest N45c584749bca400899639881a5af0e49
    142 N9155e198a16043d4b31c605c5005e7ec rdf:first sg:person.0623725744.15
    143 rdf:rest N2dbbce4d79094f04b13e8c950accf555
    144 N927b228a427149b6b7d3e6d0024569c7 rdf:first sg:person.01034467337.60
    145 rdf:rest N1f2cf4744c654ae4b8e19fb408d886ac
    146 N9f807c4839774d789d6b4dd2dabbc9e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Mammaplasty
    148 rdf:type schema:DefinedTerm
    149 Na0a1c16dbdbb4520aca5b638f97dd71a schema:name readcube_id
    150 schema:value 95f74efa61ae61448038380ccd0857ee50f03478f7a3143771f201433f8a5704
    151 rdf:type schema:PropertyValue
    152 Na8371715f4bc4a358ad89de6e5d00d62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Docetaxel
    154 rdf:type schema:DefinedTerm
    155 Nadfeef6db7494201b62ed1e976bc4554 rdf:first sg:person.01270466360.63
    156 rdf:rest N0b142972787341eb873ef427dfbae339
    157 Nb00940d777d4498aa35a160b153b7917 schema:name doi
    158 schema:value 10.1245/s10434-016-5662-9
    159 rdf:type schema:PropertyValue
    160 Nb30898ffc6a941078cfc55b37a236036 schema:name pubmed_id
    161 schema:value 27864694
    162 rdf:type schema:PropertyValue
    163 Nb62eab70716547f9ad9271951aab4946 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Bevacizumab
    165 rdf:type schema:DefinedTerm
    166 Nbebfdd79ee1748d1818d1d172e0f24d7 rdf:first sg:person.01127633164.39
    167 rdf:rest N1fd84f0b8dfa494c8a045392294a674b
    168 Nc32b4bc8a6e54c7f834261392146eb4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Breast Neoplasms
    170 rdf:type schema:DefinedTerm
    171 Nca12cb392c9e4254b677eb54746dd692 rdf:first sg:person.01034766537.68
    172 rdf:rest Nfbd036942f6747f9a856855f43716065
    173 Nd2901722d4084de09ccc250405ab3010 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Survival Rate
    175 rdf:type schema:DefinedTerm
    176 Nd62419b01cb8463d88ca8d34f66a4fd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Mastectomy
    178 rdf:type schema:DefinedTerm
    179 Nd91bc18879c4456f84805f8e11f493ea schema:name Springer Nature - SN SciGraph project
    180 rdf:type schema:Organization
    181 Ne214c0fd730e473282a354002f60f04c rdf:first sg:person.0744516345.37
    182 rdf:rest rdf:nil
    183 Nf4e6f62fb22e43f48cc556d39fa0bce0 rdf:first sg:person.07442661237.16
    184 rdf:rest N40b1b5c104c949a58afcdabf69d5da79
    185 Nfbd036942f6747f9a856855f43716065 rdf:first sg:person.01171332245.45
    186 rdf:rest N9155e198a16043d4b31c605c5005e7ec
    187 Nfc77310fe1834c7eb01bf3e62a187c95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name Prospective Studies
    189 rdf:type schema:DefinedTerm
    190 Nfcea0fb11adc49eab1aff8f1f11d7138 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    191 schema:name Follow-Up Studies
    192 rdf:type schema:DefinedTerm
    193 Nfed7ea263d804e6d855d1ed4389adfba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Surgical Wound Infection
    195 rdf:type schema:DefinedTerm
    196 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    197 schema:name Medical and Health Sciences
    198 rdf:type schema:DefinedTerm
    199 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    200 schema:name Clinical Sciences
    201 rdf:type schema:DefinedTerm
    202 sg:grant.2693540 http://pending.schema.org/fundedItem sg:pub.10.1245/s10434-016-5662-9
    203 rdf:type schema:MonetaryGrant
    204 sg:grant.3536471 http://pending.schema.org/fundedItem sg:pub.10.1245/s10434-016-5662-9
    205 rdf:type schema:MonetaryGrant
    206 sg:grant.3536478 http://pending.schema.org/fundedItem sg:pub.10.1245/s10434-016-5662-9
    207 rdf:type schema:MonetaryGrant
    208 sg:grant.3802775 http://pending.schema.org/fundedItem sg:pub.10.1245/s10434-016-5662-9
    209 rdf:type schema:MonetaryGrant
    210 sg:grant.3804391 http://pending.schema.org/fundedItem sg:pub.10.1245/s10434-016-5662-9
    211 rdf:type schema:MonetaryGrant
    212 sg:grant.3806135 http://pending.schema.org/fundedItem sg:pub.10.1245/s10434-016-5662-9
    213 rdf:type schema:MonetaryGrant
    214 sg:journal.1105545 schema:issn 1068-9265
    215 1534-4681
    216 schema:name Annals of Surgical Oncology
    217 rdf:type schema:Periodical
    218 sg:person.01020741650.38 schema:affiliation https://www.grid.ac/institutes/grid.214458.e
    219 schema:familyName Kidwell
    220 schema:givenName Kelley M.
    221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020741650.38
    222 rdf:type schema:Person
    223 sg:person.01034467337.60 schema:affiliation https://www.grid.ac/institutes/grid.266093.8
    224 schema:familyName Mehta
    225 schema:givenName Rita S.
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034467337.60
    227 rdf:type schema:Person
    228 sg:person.01034766537.68 schema:affiliation https://www.grid.ac/institutes/grid.478063.e
    229 schema:familyName Rastogi
    230 schema:givenName Priya
    231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034766537.68
    232 rdf:type schema:Person
    233 sg:person.01127411327.42 schema:affiliation https://www.grid.ac/institutes/grid.21925.3d
    234 schema:familyName Margolese
    235 schema:givenName Richard G.
    236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127411327.42
    237 rdf:type schema:Person
    238 sg:person.01127633164.39 schema:affiliation https://www.grid.ac/institutes/grid.224260.0
    239 schema:familyName Bear
    240 schema:givenName Harry D.
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127633164.39
    242 rdf:type schema:Person
    243 sg:person.01171332245.45 schema:affiliation https://www.grid.ac/institutes/grid.224260.0
    244 schema:familyName Geyer
    245 schema:givenName Charles E.
    246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171332245.45
    247 rdf:type schema:Person
    248 sg:person.01242063055.51 schema:affiliation https://www.grid.ac/institutes/grid.21925.3d
    249 schema:familyName Baez-Diaz
    250 schema:givenName Luis
    251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242063055.51
    252 rdf:type schema:Person
    253 sg:person.01270466360.63 schema:affiliation https://www.grid.ac/institutes/grid.21925.3d
    254 schema:familyName Gross
    255 schema:givenName Howard M.
    256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270466360.63
    257 rdf:type schema:Person
    258 sg:person.01277026103.87 schema:affiliation https://www.grid.ac/institutes/grid.280062.e
    259 schema:familyName Fehrenbacher
    260 schema:givenName Louis
    261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277026103.87
    262 rdf:type schema:Person
    263 sg:person.01307117455.25 schema:affiliation https://www.grid.ac/institutes/grid.21925.3d
    264 schema:familyName Brufsky
    265 schema:givenName Adam M.
    266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307117455.25
    267 rdf:type schema:Person
    268 sg:person.01314431247.04 schema:affiliation https://www.grid.ac/institutes/grid.410559.c
    269 schema:familyName Robidoux
    270 schema:givenName André
    271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314431247.04
    272 rdf:type schema:Person
    273 sg:person.014177637317.92 schema:affiliation https://www.grid.ac/institutes/grid.416912.9
    274 schema:familyName Mamounas
    275 schema:givenName Eleftherios P.
    276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014177637317.92
    277 rdf:type schema:Person
    278 sg:person.014545336422.51 schema:affiliation https://www.grid.ac/institutes/grid.15444.30
    279 schema:familyName Paik
    280 schema:givenName Soonmyung
    281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014545336422.51
    282 rdf:type schema:Person
    283 sg:person.0623725744.15 schema:affiliation https://www.grid.ac/institutes/grid.224260.0
    284 schema:familyName Zoon
    285 schema:givenName Christine K.
    286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623725744.15
    287 rdf:type schema:Person
    288 sg:person.0675501121.41 schema:affiliation https://www.grid.ac/institutes/grid.21925.3d
    289 schema:familyName Costantino
    290 schema:givenName Joseph P.
    291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675501121.41
    292 rdf:type schema:Person
    293 sg:person.0701020555.11 schema:affiliation https://www.grid.ac/institutes/grid.470273.5
    294 schema:familyName Young
    295 schema:givenName James A.
    296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701020555.11
    297 rdf:type schema:Person
    298 sg:person.0715716543.14 schema:affiliation https://www.grid.ac/institutes/grid.48336.3a
    299 schema:familyName Gaur
    300 schema:givenName Rakesh
    301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715716543.14
    302 rdf:type schema:Person
    303 sg:person.0743272655.74 schema:affiliation https://www.grid.ac/institutes/grid.21925.3d
    304 schema:familyName Tang
    305 schema:givenName Gong
    306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743272655.74
    307 rdf:type schema:Person
    308 sg:person.07442661237.16 schema:affiliation https://www.grid.ac/institutes/grid.411667.3
    309 schema:familyName Swain
    310 schema:givenName Sandra M.
    311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07442661237.16
    312 rdf:type schema:Person
    313 sg:person.0744516345.37 schema:affiliation https://www.grid.ac/institutes/grid.417046.0
    314 schema:familyName Wolmark
    315 schema:givenName Norman
    316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744516345.37
    317 rdf:type schema:Person
    318 sg:person.0747133755.49 schema:affiliation https://www.grid.ac/institutes/grid.492880.f
    319 schema:familyName Senecal
    320 schema:givenName Francis M.
    321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747133755.49
    322 rdf:type schema:Person
    323 sg:person.07743640715.33 schema:affiliation https://www.grid.ac/institutes/grid.415497.a
    324 schema:familyName Adams
    325 schema:givenName Paul T.
    326 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07743640715.33
    327 rdf:type schema:Person
    328 sg:pub.10.1007/s00268-009-0251-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002430554
    329 https://doi.org/10.1007/s00268-009-0251-8
    330 rdf:type schema:CreativeWork
    331 sg:pub.10.1007/s00384-011-1360-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1022743009
    332 https://doi.org/10.1007/s00384-011-1360-z
    333 rdf:type schema:CreativeWork
    334 sg:pub.10.1007/s10549-013-2682-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1003608302
    335 https://doi.org/10.1007/s10549-013-2682-z
    336 rdf:type schema:CreativeWork
    337 sg:pub.10.1007/s10549-016-3889-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022566981
    338 https://doi.org/10.1007/s10549-016-3889-6
    339 rdf:type schema:CreativeWork
    340 sg:pub.10.1007/s11060-014-1482-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013120563
    341 https://doi.org/10.1007/s11060-014-1482-6
    342 rdf:type schema:CreativeWork
    343 sg:pub.10.1007/s11060-015-1868-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049649008
    344 https://doi.org/10.1007/s11060-015-1868-0
    345 rdf:type schema:CreativeWork
    346 sg:pub.10.1007/s40265-014-0302-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034241465
    347 https://doi.org/10.1007/s40265-014-0302-9
    348 rdf:type schema:CreativeWork
    349 sg:pub.10.1038/362841a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013132150
    350 https://doi.org/10.1038/362841a0
    351 rdf:type schema:CreativeWork
    352 sg:pub.10.1245/s10434-010-1366-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043413784
    353 https://doi.org/10.1245/s10434-010-1366-8
    354 rdf:type schema:CreativeWork
    355 sg:pub.10.1245/s10434-013-3442-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038883660
    356 https://doi.org/10.1245/s10434-013-3442-3
    357 rdf:type schema:CreativeWork
    358 https://app.dimensions.ai/details/publication/pub.1078308596 schema:CreativeWork
    359 https://app.dimensions.ai/details/publication/pub.1083175627 schema:CreativeWork
    360 https://doi.org/10.1002/0471249688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1098661133
    361 rdf:type schema:CreativeWork
    362 https://doi.org/10.1002/cncr.25573 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034217020
    363 rdf:type schema:CreativeWork
    364 https://doi.org/10.1016/j.clbc.2011.04.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015515225
    365 rdf:type schema:CreativeWork
    366 https://doi.org/10.1016/j.ctrv.2014.05.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041901798
    367 rdf:type schema:CreativeWork
    368 https://doi.org/10.1016/j.ejca.2011.11.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020551811
    369 rdf:type schema:CreativeWork
    370 https://doi.org/10.1016/j.ejso.2011.06.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024788330
    371 rdf:type schema:CreativeWork
    372 https://doi.org/10.1016/j.jocn.2014.05.054 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008673264
    373 rdf:type schema:CreativeWork
    374 https://doi.org/10.1016/s1470-2045(09)70341-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028408070
    375 rdf:type schema:CreativeWork
    376 https://doi.org/10.1016/s1470-2045(13)70335-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030458704
    377 rdf:type schema:CreativeWork
    378 https://doi.org/10.1016/s1470-2045(15)00041-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050365925
    379 rdf:type schema:CreativeWork
    380 https://doi.org/10.1056/nejm197108122850711 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042994614
    381 rdf:type schema:CreativeWork
    382 https://doi.org/10.1056/nejm197111182852108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031952402
    383 rdf:type schema:CreativeWork
    384 https://doi.org/10.1056/nejmoa072113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033842397
    385 rdf:type schema:CreativeWork
    386 https://doi.org/10.1056/nejmoa1111097 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014405968
    387 rdf:type schema:CreativeWork
    388 https://doi.org/10.1093/annonc/mdt361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014803302
    389 rdf:type schema:CreativeWork
    390 https://doi.org/10.1093/annonc/mdu455 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038938305
    391 rdf:type schema:CreativeWork
    392 https://doi.org/10.1097/cad.0b013e328349c7bb schema:sameAs https://app.dimensions.ai/details/publication/pub.1033215039
    393 rdf:type schema:CreativeWork
    394 https://doi.org/10.1097/sap.0b013e3181828141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039490245
    395 rdf:type schema:CreativeWork
    396 https://doi.org/10.1097/sap.0b013e31824e5e57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028219190
    397 rdf:type schema:CreativeWork
    398 https://doi.org/10.1158/0008-5472.sabcs13-s1-03 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063223427
    399 rdf:type schema:CreativeWork
    400 https://doi.org/10.1158/1538-7445.sabcs15-s2-05 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063275973
    401 rdf:type schema:CreativeWork
    402 https://doi.org/10.1200/jco.2008.17.7857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039795259
    403 rdf:type schema:CreativeWork
    404 https://doi.org/10.1200/jco.2008.21.6457 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046932078
    405 rdf:type schema:CreativeWork
    406 https://doi.org/10.1200/jco.2010.28.0982 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032315475
    407 rdf:type schema:CreativeWork
    408 https://doi.org/10.2217/fon.12.22 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006755830
    409 rdf:type schema:CreativeWork
    410 https://doi.org/10.3322/canjclin.22.4.226 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049016780
    411 rdf:type schema:CreativeWork
    412 https://www.grid.ac/institutes/grid.15444.30 schema:alternateName Yonsei University
    413 schema:name NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    414 Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea
    415 rdf:type schema:Organization
    416 https://www.grid.ac/institutes/grid.214458.e schema:alternateName University of Michigan–Ann Arbor
    417 schema:name Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA
    418 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    419 University of Pittsburgh, Pittsburgh, PA, USA
    420 rdf:type schema:Organization
    421 https://www.grid.ac/institutes/grid.21925.3d schema:alternateName University of Pittsburgh
    422 schema:name Dayton CCOP, Dayton, OH, USA
    423 Jewish General Hospital, McGill University, Montréal, QC, Canada
    424 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    425 San Juan MBCCOP, San Juan, PR, USA
    426 University of Pittsburgh, Pittsburgh, PA, USA
    427 University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA, USA
    428 rdf:type schema:Organization
    429 https://www.grid.ac/institutes/grid.224260.0 schema:alternateName Virginia Commonwealth University
    430 schema:name Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA
    431 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    432 rdf:type schema:Organization
    433 https://www.grid.ac/institutes/grid.266093.8 schema:alternateName University of California, Irvine
    434 schema:name NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    435 School of Medicine, Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange, CA, USA
    436 rdf:type schema:Organization
    437 https://www.grid.ac/institutes/grid.280062.e schema:alternateName Kaiser Permanente
    438 schema:name Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA, USA
    439 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    440 rdf:type schema:Organization
    441 https://www.grid.ac/institutes/grid.410559.c schema:alternateName Centre Hospitalier de l’Université de Montréal
    442 schema:name Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, QC, Canada
    443 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    444 rdf:type schema:Organization
    445 https://www.grid.ac/institutes/grid.411667.3 schema:alternateName Georgetown University Medical Center
    446 schema:name Georgetown University Medical Center, Washington, DC, USA
    447 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    448 Washington Cancer Institute, Washington Hospital Center, Washington, DC, USA
    449 rdf:type schema:Organization
    450 https://www.grid.ac/institutes/grid.415497.a schema:alternateName Genesys Regional Medical Center
    451 schema:name Genesys Regional Medical Center, Grand Blanc, MI, USA
    452 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    453 rdf:type schema:Organization
    454 https://www.grid.ac/institutes/grid.416912.9 schema:alternateName Orlando Health
    455 schema:name NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    456 UF Health Cancer Center at Orlando Health, Orlando, FL, USA
    457 rdf:type schema:Organization
    458 https://www.grid.ac/institutes/grid.417046.0 schema:alternateName Allegheny Health Network
    459 schema:name Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA
    460 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    461 rdf:type schema:Organization
    462 https://www.grid.ac/institutes/grid.470273.5 schema:alternateName Colorado Cancer Research Program
    463 schema:name CCOP, Colorado Cancer Research Program, Colorado Springs, CO, USA
    464 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    465 rdf:type schema:Organization
    466 https://www.grid.ac/institutes/grid.478063.e schema:alternateName University of Pittsburgh Cancer Institute
    467 schema:name NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    468 University of Pittsburgh Cancer Institute School of Medicine, Pittsburgh, PA, USA
    469 rdf:type schema:Organization
    470 https://www.grid.ac/institutes/grid.48336.3a schema:alternateName National Cancer Institute
    471 schema:name Kansas City Clinical Oncology Program, Kansas City, MO, USA
    472 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    473 rdf:type schema:Organization
    474 https://www.grid.ac/institutes/grid.492880.f schema:alternateName Northwest Medical Specialties
    475 schema:name CCOP, North-West Medical Specialties, Tacoma, WA, USA
    476 NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA
    477 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...